{
    "clinical_study": {
        "@rank": "112598", 
        "acronym": "2011-11-004", 
        "arm_group": [
            {
                "arm_group_label": "C -> C + S", 
                "arm_group_type": "Experimental", 
                "description": "cilostazol (C) in period 1, cilostazol + simvastatin (C+S) in period 2"
            }, 
            {
                "arm_group_label": "C+S -> C", 
                "arm_group_type": "Experimental", 
                "description": "cilostazol + simvastatin (C+S) in period 1, cilostazol (C) in period 2"
            }, 
            {
                "arm_group_label": "S -> S + C", 
                "arm_group_type": "Experimental", 
                "description": "simvastatin (S) in period 1, simvastatin + cilostazol (S+C) in period 2"
            }, 
            {
                "arm_group_label": "C + S -> S", 
                "arm_group_type": "Experimental", 
                "description": "cilostazol + simvastatin (C+S) in period 1, simvastatin (S) in period 2"
            }, 
            {
                "arm_group_label": "R -> C + R", 
                "arm_group_type": "Experimental", 
                "description": "rosuvastatin (R) in period 1, cilostazol + rosuvastatin (C+R) in period 2"
            }, 
            {
                "arm_group_label": "C + R -> R", 
                "arm_group_type": "Experimental", 
                "description": "cilostazol + rosuvastatin (C+R) in period 1, rosuvastatin (R) in period 2"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate pharmacodynamic drug interaction between cilostazol\n      and statins (simvastatin as a CYP3A substrate and rosuvastatin as a non-CYP3A substrate) in\n      healthy male subjects."
        }, 
        "brief_title": "Pharmacodynamic Drug Interaction Between Cilostazol and Statins", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Healthy", 
        "detailed_description": {
            "textblock": "Subjects suitable for this study will visit to the Clinical Trial Center, Samsung Medical\n      Center for 7 days and pharmacodynamic samplings will be performed following the\n      administration of study drugs."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy male subjects aged 20 - 55 years\n\n          -  A body mass index in the range 18.5 - 27 kg/m2\n\n          -  Willingness to participate during the entire study period\n\n          -  Written informed consent after being fully informed about the study procedures\n\n        Exclusion Criteria:\n\n          -  Any past medical history of hepatic, renal, neurologic, cardiovascular, respiratory,\n             endocrine, hemato-oncologic or psychiatric disease\n\n          -  Active bleeding or bleeding tendency\n\n          -  History of gastrointestinal disease or surgery possibly affecting drug absorption\n\n          -  History of clinically significant drug hypersensitivity\n\n          -  Use of medication within 7 days before the first dose\n\n          -  Heavy drinker (>140 g/week)\n\n          -  Whole blood donation during 60 days before the study\n\n          -  Judged not eligible for study participation by investigator"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "55 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 4, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01870466", 
            "org_study_id": "SMCCPT-100"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "C -> C + S", 
                    "C+S -> C", 
                    "S -> S + C", 
                    "C + S -> S", 
                    "R -> C + R", 
                    "C + R -> R"
                ], 
                "description": "cilostazol bid for 7 days", 
                "intervention_name": "C", 
                "intervention_type": "Drug", 
                "other_name": "cilostazol (C); Plettal 100 mg"
            }, 
            {
                "arm_group_label": [
                    "C -> C + S", 
                    "C+S -> C", 
                    "S -> S + C", 
                    "C + S -> S"
                ], 
                "description": "simvastatin qd for 7 days", 
                "intervention_name": "S", 
                "intervention_type": "Drug", 
                "other_name": "simvastatin (S); Zocor 40 mg"
            }, 
            {
                "arm_group_label": [
                    "R -> C + R", 
                    "C + R -> R"
                ], 
                "description": "rosuvastatin qd for 7 days", 
                "intervention_name": "R", 
                "intervention_type": "Drug", 
                "other_name": "Rosuvastatin (R); Crestor 20 mg"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Cilostazol", 
                "Simvastatin", 
                "Rosuvastatin"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "June 3, 2013", 
        "location": {
            "contact": {
                "email": "jw0701.ko@samsung.com", 
                "last_name": "JaeWook Ko, MD, PhD", 
                "phone": "82-2-3410-3690"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of"
                }, 
                "name": "Samsung Medical Center"
            }, 
            "investigator": {
                "last_name": "JaeWook Ko, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "6", 
        "official_title": "A Randomized, Open-label, Multiple-dose, Crossover Study to Investigate the Pharmacodynamic Drug Interaction Between Cilostazol and Statins in Healthy Male Volunteer", 
        "overall_official": {
            "affiliation": "Samsung Medical Center", 
            "last_name": "Jae-Wook Ko, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "South Korea: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "October 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "lipid panel", 
            "measure": "lipid lowering effect", 
            "safety_issue": "No", 
            "time_frame": "7 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01870466"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Samsung Medical Center", 
            "investigator_full_name": "JaeWook  Ko", 
            "investigator_title": "Professor, Department of Clinical Pharmacology and Therapeutics", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "platelet aggregation test", 
            "measure": "anti-platelet effect", 
            "safety_issue": "No", 
            "time_frame": "7 days"
        }, 
        "source": "Samsung Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Samsung Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}